Company Announcements

In November 2017, drug discovery company Cronin Group acquired OpenIOLabs, which develops hardware and software for scientific and industrial uses. OpenIOLabs provides open source hardware platform for organizations working with multiple pieces of equipment. In 2016, OpenIOLabs generated revenues of £77,694 ($102,229).

CSols announced in December 2017 the establishment of its Dendrite Labs business, which provides software solutions to improve lab efficiency. Dendrite Labs offers Instrument LabTiles, which provides a dashboard display of instrument data.

LIMS provider Ovation.io announced in December 2017 a partnership with Coriell Life Sciences, a provider of clinical genetic reporting solutions, to create a seamless ecosystem for sample and workflow management, genetic data interpretation and external client communication.

Ovation.io closed an expanded $18.5 million round of financing in January.

ELN firm Collaborative Drug Discovery announced the receipt of a $1.5 million US Small Business Innovation Research grant entitled, “Comprehensive But Simple Encoding of Bioassays to Accelerate Translational Drug Discovery.”

In January, bioinformatics and genomics profiling company Strand Life Sciences announced a merger with Healthcare Global Enterprises’ Triesta Sciences business, which provides molecular diagnostics services for oncology.

In January, KineMatik named Delaware as an authorized partner.

KineMatik named in January Mannai Trading as an authorized partner for Qatar.

Clarivate Analytics named Mukhtar Ahmed as president of its Life Sciences division. He previously held executive posts at Oracle, Parexel and Kendle.

In January, OWKIN, a predictive analytics company, closed an $11 million Series A financing round, bringing the company’s total financing to $13.1 million in one year.

In January, Riffyn, provider of a cloud-based Scientific Development Environment, opened an office in Boston, Massachusetts. The company more than doubled its staff in 2017.

Bio-IT firm BioBright announced in January a collaboration with the Wellcome Sanger Institute with the aim of faster development of drugs for diseases of the immune system.

Qlucore partnered with Nebion in January to make it easier to combine their respective Omics Explorer and Geneinvestigator tools for investigating RNA-seq gene expression data.

In January, Cogenica appointed David Atkins, PhD, as CEO and a Board member. He was previously CEO of Synevo, a clinical diagnostics lab service business.

Product Introductions

IDBS introduced in December 2017 an extension of its E-WorkBook Connect cloud-based platform to include a synthetic chemistry offering.

In December 2017, BioSymetrics launched the Augusta pre-processing and analytics platform for standardized processing and integration of multiple, diverse raw data type to facilitate and deploy AI projects. The platform features over 150 modules for processing raw genomic, metabolomics, MRI/fMRI, chemical ECG/EEG and EMR data.

Genedata announced in December that it has launched a cloud-based deployment of its Genedata Profiler software on platforms such as Microsoft Azure and Amazon Web Services.

In January, Genedata launched the Genedata Selector for Precise Genome Editing for data management and analysis of CRISPR-related genomic data.

Genedata announced in January the release of Genedata Screener 15, which features extended support of large-scale mechanistic analyses and new automation features. It includes new instrument integrations with the Creoptix WAVE, Pall ForteBio Octet and Sierra Sensors MASS. In addition, a new web-accessible version is available.

Sales and Orders of Note

In December 2017, Cresset announced that software and contract research services provider Proximagen has licensed its Flare platform for structure-based design.

Autoscribe Informatics announced in January that Clatterbridge Cancer Center is using its Matrix Gemini LIMS.

Certara announced in January that the Brazilian National Health Surveillance Agency has adopted its Phoenix WinNonlin software for reviewing drug regulatory submissions.

The RWTH Aachen University’s Center for Biohybrid Medical Systems has adopted labfolder’s ELN.